MM Pizzichini, E Pizzichini, L Clelland, A Efthimiadis, J Mahony, J Dolovich and FE Hargreave
Department of Medicine, St. Joseph's Hospital and McMaster University, Hamilton, Ontario, Canada.

We have investigated the time-course of symptoms, forced expiratory volume in one second (FEV1), and the airway inflammatory changes in sputum selected from saliva and blood of 10 patients with severe exacerbation of asthma betwen presentation and after 1, 2, 3, 7, and 21 days of treatment. The sputum was induced by a modified standard protocol, and we examined its safety. The severe exacerbation of asthma was defined by the presence of nocturnal symptoms disturbing sleep and/or the need for inhaled short acting beta2-agonist > or = 8 puffs/d and an FEV1 after bronchodilator < 60% of predicted. The treatment consisted of additional prednisone 30 mg daily for 5 d followed by reduction to zero by day 10. Abnormal findings [median (interquartile range)] in spontaneous and induced sputum included low viability of cells [52.0 (34.0)%]; eosinophilia [20.0 (16.4)%]; many free eosinophil granules; and increased levels of fluid-phase ECP [1960 (9204) microg/L], fibrinogen [6045 (10720) microg/L], and IL-5 [160 (212) pg/ml]. Peripheral blood eosinophils [10.4 (7.6)%] and ECP levels [34.0 (35.0) microg/L] were increased. After treatment, symptoms, FEV1, blood eosinophilia, and serum ECP improved in the first 24 h. Sputum eosinophils and ECP did not improve until 48 h and fibrinogen not until 7 d. The improvement in sputum eosinophils and ECP levels was correlated with improvement of FEV1 and in fluid-phase IL-5. Thirty sputum inductions were performed safely in the majority with inhaled isotonic or 3% saline (23.3% or 63.3%, respectively) over a short duration (mean 8.4 min). The patients who had a fall in FEV1 of > or = 10% (10 occasions) after induction differed from those with a fall of < 10% only in the amount of inhaled beta2-agonist used by the patients in the preceding 24 h [8.0 (5.0) versus 4.0 (3.0) puffs/d, p = 0.01]. The results suggest that spontaneous or induced sputum can be used safely to follow the kinetics of effects of antiinflammatory treatment in a severe exacerbation of asthma. The clinical and blood indices improve before those in sputum, raising the possibility that examination of sputum is a better guide in these patients to follow the effects of treatment.

This article has been cited by other articles:

				J. Belda, G. Margarit, C. Martinez, J. Bellido-Casado, P. Casan, M. Torrejon, M. Brufal, F. Rodriguez-Jerez, and J. Sanchis Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations Eur. Respir. J., December 1, 2007; 30(6): 1143 - 1149. [Abstract] [Full Text] [PDF]

				E. Bathoorn, D-J. Slebos, D. S. Postma, G. H. Koeter, A. J. M. van Oosterhout, M. van der Toorn, H. M. Boezen, and H. A. M. Kerstjens Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study Eur. Respir. J., December 1, 2007; 30(6): 1131 - 1137. [Abstract] [Full Text] [PDF]

				K. Maneechotesuwan, S. Essilfie-Quaye, S. A. Kharitonov, I. M. Adcock, and P. J. Barnes Loss of Control of Asthma Following Inhaled Corticosteroid Withdrawal Is Associated With Increased Sputum Interleukin-8 and Neutrophils Chest, July 1, 2007; 132(1): 98 - 105. [Abstract] [Full Text] [PDF]

				C. Carlsten, M. L. Aitken, and T. S. Hallstrand Safety of Sputum Induction With Hypertonic Saline Solution in Exercise-Induced Bronchoconstriction Chest, May 1, 2007; 131(5): 1339 - 1344. [Abstract] [Full Text] [PDF]

				E. Bathoorn, J. Liesker, D. Postma, G. Koeter, A. J. M. van Oosterhout, and H. A. M. Kerstjens Safety of Sputum Induction During Exacerbations of COPD Chest, February 1, 2007; 131(2): 432 - 438. [Abstract] [Full Text] [PDF]

				H. K. Reddel and D. J. Barnes Pharmacological strategies for self-management of asthma exacerbations. Eur. Respir. J., July 1, 2006; 28(1): 182 - 199. [Abstract] [Full Text] [PDF]

				A.-S. Jang, J.-H. Lee, S. W. Park, Y. M. Lee, S. T. Uh, Y.-H. Kim, and C.-S. Park Factors Influencing the Responsiveness to Inhaled Glucocorticoids of Patients With Moderate-to-Severe Asthma Chest, September 1, 2005; 128(3): 1140 - 1145. [Abstract] [Full Text] [PDF]

				K. Kostikas, M. Gaga, G. Papatheodorou, T. Karamanis, D. Orphanidou, and S. Loukides Leukotriene B4 in Exhaled Breath Condensate and Sputum Supernatant in Patients With COPD and Asthma Chest, May 1, 2005; 127(5): 1553 - 1559. [Abstract] [Full Text] [PDF]

				R. A. Pauwels Similarities and Differences in Asthma and Chronic Obstructive Pulmonary Disease Exacerbations Proceedings of the ATS, April 1, 2004; 1(2): 73 - 76. [Abstract] [Full Text] [PDF]

				J. A. Wedzicha Role of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2004; 1(2): 115 - 120. [Abstract] [Full Text] [PDF]

				M Delvaux, M Henket, L Lau, P Kange, P Bartsch, R Djukanovic, and R Louis Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma Thorax, February 1, 2004; 59(2): 111 - 115. [Abstract] [Full Text] [PDF]

				S. S. Birring, D. Parker, C. E. Brightling, P. Bradding, A. J. Wardlaw, and I. D. Pavord Induced Sputum Inflammatory Mediator Concentrations in Chronic Cough Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 15 - 19. [Abstract] [Full Text] [PDF]

				K. Kostikas, G. Papatheodorou, K. Psathakis, P. Panagou, and S. Loukides Oxidative Stress in Expired Breath Condensate of Patients With COPD Chest, October 1, 2003; 124(4): 1373 - 1380. [Abstract] [Full Text] [PDF]

				B. M. Saraiva-Romanholo, V. Barnabe, A. L. I. Carvalho, M. A. Martins, P. H. N. Saldiva, and M. d. P. T. Nunes Comparison of Three Methods for Differential Cell Count in Induced Sputum Chest, September 1, 2003; 124(3): 1060 - 1066. [Abstract] [Full Text] [PDF]

				R. Taha, Q. Hamid, L. Cameron, and R. Olivenstein T Helper Type 2 Cytokine Receptors and Associated Transcription Factors GATA-3, c-MAF, and Signal Transducer and Activator of Transcription Factor-6 in Induced Sputum of Atopic Asthmatic Patients Chest, June 1, 2003; 123(6): 2074 - 2082. [Abstract] [Full Text] [PDF]

				C E Brightling, F A Symon, S S Birring, P Bradding, A J Wardlaw, and I D Pavord Comparison of airway immunopathology of eosinophilic bronchitis and asthma Thorax, June 1, 2003; 58(6): 528 - 532. [Abstract] [Full Text] [PDF]

				R.O. Crapo, R.L. Jensen, and F.E. Hargreave Airway inflammation in COPD: physiological outcome measures and induced sputum Eur. Respir. J., June 1, 2003; 21(41_suppl): 19S - 28s. [Abstract] [Full Text] [PDF]

				J. M. FitzGerald Broadening the Therapeutic Options in Acute Asthma Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 488 - 489. [Full Text] [PDF]

				P. Godon, L-P. Boulet, J-L. Malo, A. Cartier, and C. Lemiere Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids Eur. Respir. J., December 1, 2002; 20(6): 1364 - 1369. [Abstract] [Full Text] [PDF]

				M. G. Kelly, V. Brown, S. L. Martin, M. Ennis, and J. S. Elborn Comparison of Sputum Induction Using High-Output and Low-Output Ultrasonic Nebulizers in Normal Subjects and Patients With COPD* Chest, September 1, 2002; 122(3): 955 - 959. [Abstract] [Full Text] [PDF]

				E. Bacci, A. Di Franco, M.L. Bartoli, S. Carnevali, S. Cianchetti, F.L. Dente, D. Giannini, B. Vagaggini, L. Ruocco, and P.L. Paggiaro Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma Eur. Respir. J., July 1, 2002; 20(1): 66 - 72. [Abstract] [Full Text] [PDF]

				Leader of the Working Group: P.L. Paggiaro, Members of the Working Group:, P. Chanez, O. Holz, P.W. Ind, R. Djukanovic, P. Maestrelli, and P.J. Sterk Sputum induction Eur. Respir. J., July 1, 2002; 20(37_suppl): 3S - 8s. [Full Text] [PDF]

				Leader of the Working Group: E. Pizzichini, Members of the Working Group:, M.M.M. Pizzichini, R. Leigh, R. Djukanovic, and P.J. Sterk Safety of sputum induction Eur. Respir. J., July 1, 2002; 20(37_suppl): 9S - 18s. [Full Text] [PDF]

				Leader of the Working Group: M.M. Kelly, Members of the Working Group:, V. Keatings, R. Leigh, C. Peterson, J. Shute, P. Venge, and R. Djukanovic Analysis of fluid{-}phase mediators Eur. Respir. J., July 1, 2002; 20(37_suppl): 24S - 39s. [Full Text] [PDF]

				Leader of the Working Group:, J.C. Kips, Members of the Working Group:, M.D. Inman, L. Jayaram, E.H. Bel, K. Parameswaran, M.M.M. Pizzichini, I.D. Pavord, R. Djukanovic, et al. The use of induced sputum in clinical trials Eur. Respir. J., July 1, 2002; 20(37_suppl): 47S - 50s. [Full Text] [PDF]

				K. Kostikas, G. Papatheodorou, K. Ganas, K. Psathakis, P. Panagou, and S. Loukides pH in Expired Breath Condensate of Patients with Inflammatory Airway Diseases Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1364 - 1370. [Abstract] [Full Text] [PDF]

				K. Minoguchi, Y. Kohno, H. Minoguchi, N. Kihara, Y. Sano, H. Yasuhara, and M. Adachi Reduction of Eosinophilic Inflammation in the Airways of Patients With Asthma Using Montelukast Chest, March 1, 2002; 121(3): 732 - 738. [Abstract] [Full Text] [PDF]

				S. Loukides, D. Bouros, G. Papatheodorou, P. Panagou, and N. M. Siafakas The Relationships Among Hydrogen Peroxide in Expired Breath Condensate, Airway Inflammation, and Asthma Severity Chest, February 1, 2002; 121(2): 338 - 346. [Abstract] [Full Text] [PDF]

				S. Loukides, D. Bouros, G. Papatheodorou, S. Lachanis, P. Panagou, and N. M. Siafakas Exhaled H2O2 in Steady-State Bronchiectasis : Relationship With Cellular Composition in Induced Sputum, Spirometry, and Extent and Severity of Disease Chest, January 1, 2002; 121(1): 81 - 87. [Abstract] [Full Text] [PDF]

				D. Cataldo, J.-M. Foidart, L. Lau, P. Bartsch, R. Djukanovic, and R. Louis Induced Sputum : Comparison Between Isotonic and Hypertonic Saline Solution Inhalation in Patients With Asthma Chest, December 1, 2001; 120(6): 1815 - 1821. [Abstract] [Full Text] [PDF]

				R. G. STIRLING, E. L. J. VAN RENSEN, P. J. BARNES, and K. FAN CHUNG Interleukin-5 Induces CD34+ Eosinophil Progenitor Mobilization and Eosinophil CCR3 Expression in Asthma Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1403 - 1409. [Abstract] [Full Text] [PDF]

				M.M. Kelly, R. Leigh, S. Carruthers, P. Horsewood, G.J. Gleich, F.E. Hargreave, and G. Cox Increased detection of interleukin-;5 in sputum by addition of protease inhibitors Eur. Respir. J., October 1, 2001; 18(4): 685 - 691. [Abstract] [Full Text] [PDF]

				C. Lemiere, C. Walker, D. O'Shaughnessy, A. Efthimiadis, F. E. Hargreave, and M. R. Sears Differential Cell Counts in Sputum in Respiratory Epidemiology : A Pilot Study Chest, October 1, 2001; 120(4): 1107 - 1113. [Abstract] [Full Text] [PDF]

				A. ten BRINKE, C. de LANGE, A. H. ZWINDERMAN, K. F. RABE, P. J. STERK, and E. H. BEL Sputum Induction in Severe Asthma by a Standardized Protocol . Predictors of Excessive Bronchoconstriction Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 749 - 753. [Abstract] [Full Text] [PDF]

				R. A. Taha, S. Laberge, Q. Hamid, and R. Olivenstein Increased Expression of the Chemoattractant Cytokines Eotaxin, Monocyte Chemotactic Protein-4, and Interleukin-16 in Induced Sputum in Asthmatic Patients Chest, August 1, 2001; 120(2): 595 - 601. [Abstract] [Full Text] [PDF]

				J. Belda, J. Giner, P. Casan, and J. Sanchis Mild Exacerbations and Eosinophilic Inflammation in Patients With Stable, Well-Controlled Asthma After 1 Year of Follow-up Chest, April 1, 2001; 119(4): 1011 - 1017. [Abstract] [Full Text] [PDF]

				D.C. Grootendorst, P.J. Sterk, and H.G.M. Heijerman Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma Eur. Respir. J., March 1, 2001; 17(3): 374 - 379. [Abstract] [Full Text] [PDF]

				P. G. GIBSON, N. SALTOS, and K. FAKES Acute Anti-inflammatory Effects of Inhaled Budesonide in Asthma . A Randomized Controlled Trial Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 32 - 36. [Abstract] [Full Text]

				C. E. BRIGHTLING, R. WARD, G. WOLTMANN, P. BRADDING, J. R. SHELLER, R. DWORSKI, and I. D. PAVORD Induced Sputum Inflammatory Mediator Concentrations in Eosinophilic Bronchitis and Asthma Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 878 - 882. [Abstract] [Full Text]

				J. Tamaoki, M. Kondo, J. Nakata, Y. Nagano, K. Isono, and A. Nagai Effect of a Thromboxane A2 Antagonist on Sputum Production and Its Physicochemical Properties in Patients With Mild to Moderate Asthma Chest, July 1, 2000; 118(1): 73 - 79. [Abstract] [Full Text] [PDF]

				M. Z. NORZILA, K. FAKES, R. L. HENRY, J. SIMPSON, and P. G. GIBSON Interleukin-8 Secretion and Neutrophil Recruitment Accompanies Induced Sputum Eosinophil Activation in Children with Acute Asthma Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 769 - 774. [Abstract] [Full Text] [PDF]

				E. Rosi and G. Scano Association of sputum parameters with clinical and functional measurements in asthma Thorax, March 1, 2000; 55(3): 235 - 238. [Full Text]

				A. Bhowmik, T. A R Seemungal, R. J Sapsford, and J. A Wedzicha Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations Thorax, February 1, 2000; 55(2): 114 - 120. [Abstract] [Full Text]

				A. JATAKANON, S. LIM, and P. J. BARNES Changes in Sputum Eosinophils Predict Loss of Asthma Control Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 64 - 72. [Abstract] [Full Text]

				A. JATAKANON, C. UASUF, W. MAZIAK, S. LIM, K. F. CHUNG, and P. J. BARNES Neutrophilic Inflammation in Severe Persistent Asthma Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1532 - 1539. [Abstract] [Full Text]

				F. E. HARGREAVE and R. LEIGH Induced Sputum, Eosinophilic Bronchitis, and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S53 - 57. [Abstract] [Full Text] [PDF]

				A. B CHANG    Isolated cough: probably not asthma Arch. Dis. Child., March 1, 1999; 80(3): 211 - 213. [Full Text]

				A. Jatakanon, S. Kharitonov, S. Lim, and P. J Barnes Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma Thorax, February 1, 1999; 54(2): 108 - 114. [Abstract] [Full Text]

				R G Stirling, S A Kharitonov, D Campbell, D S Robinson, S R Durham, K F Chung, and P J Barnes Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids Thorax, December 1, 1998; 53(12): 1030 - 1034. [Abstract] [Full Text]

				E. PIZZICHINI, M. M. M. PIZZICHINI, P. GIBSON, K. PARAMESWARAN, G. J. GLEICH, L. BERMAN, J. DOLOVICH, and F. E. HARGREAVE Sputum Eosinophilia Predicts Benefit from Prednisone in Smokers with Chronic Obstructive Bronchitis Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1511 - 1517. [Abstract] [Full Text] [PDF]

				M. M. M. PIZZICHINI, E. PIZZICHINI, A. EFTHIMIADIS, A. J. CHAUHAN, S. L. JOHNSTON, P. HUSSACK, J. MAHONY, J. DOLOVICH, and F. E. HARGREAVE Asthma and Natural Colds . Inflammatory Indices in Induced Sputum: A Feasibility Study Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1178 - 1184. [Abstract] [Full Text] [PDF]